Market News

OMXSTO:XBRANE News

2 stories
modular_finance

Xbrane Biopharma (Q2 review): Crucial months ahead, BsUFA in October

Redeye’s analyst just published a Research Update on Xbrane Biopharma.Click here to read the articleMake sure to add Xbrane Biopharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.This is a press release from Redeye - Nordic Growt…

MFN by Modular Finance en_IN
StocksSE
modular_finance

Xbrane Biopharma releases Interim Report for January-June 2026

Xbrane Biopharma AB’s (publ.) (” Xbrane”) Interim Report for January-June 2026, is as of today, available on the Company’s website, www.xbrane.com.FINANCIAL OVERVIEWSECOND QUARTER 2026*• Revenue amounted to SEK 46.8 m (39.9).• Other operating income amounted to SEK 6.2 m (3,1).• EBITDA amounted to…

MFN by Modular Finance en_IN
StocksSE